Improvement in Growth of Children With Crohn Disease Following Anti‐TNF‐α Therapy Can Be Independent of Pubertal Progress and Glucocorticoid Reduction

Abstract

Clinical response to infliximab therapy is associated with an improvement in linear growth in the short term in children with CD. This increase in height may not be simply due to progress in pubertal status or reduction in GC dose.